Stock Ticker

  • Loading stock data...

Allergan, Inc. (NYSE:AGN) Loses Latisse Eyelash Ruling; Rejects Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Offer

Boston, MA 06/11/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN), the Botox wrinkle therapy maker, lost a ruling in the appeals court which will cause generic versions of the company’s Latisse eyelash medicine enter the marketplace. Ruling Rejected Allergan, Inc. (NYSE:AGN) and Duke University owned two patents on its drug Latisse but as per the website posting, […]